Loading clinical trials...
Loading clinical trials...
This study evaluated the effectiveness and safety of improving Mild Dementia by applying tDCS for 26 weeks to patients with Mild Dementia.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ybrain Inc.
NCT06121544 · Alzheimer Disease, Mild Cognitive Impairment, and more
NCT07027072 · Mild Cognitive Impairment (MCI), Mild Dementia, and more
NCT05910619 · Mild Dementia, Aging Well
NCT06704971 · Mild Cognitive Impairment, Mild Dementia, and more
NCT03430401 · Mild Cognitive Impairment, Mild Dementia, and more
The Catholic University of Korea at incheon
Incheon
Korea University
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions